1Wani MC,Taylot HI., Wail ME, et al. Plant anbitnmor agents VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent form Taxos brcvifalia[J]. JAMA,1971,93:2325 被引量：1
2Horwitz SB,Cohen D,Rao S,et al. Taxol:mechanismas of action and resistance[J]. J Natl Cancer Inst, 1993,15:55 被引量：1
2Hoff PM,Fuchs CS.The experience with oxaliplatin in the treatment of upper gastrointestinal carcinomas[J].Semin Oncol,2003,30:54 被引量：1
3De Gramont A,Figer A,Seymonr M,et al.Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer[J].Clin Oncol,2000,18:2938 被引量：1
5Louvet C,Andre T,Tigaud JM,et al.Phase Ⅱ study of oxaliplatin,fluorouracil and folinic acid in locally advanced or metastatic gastric cancer patients[J].Clin Oncol,2002,20(23):4543. 被引量：1
6Seidman AD,Tiersten A,Hudis C, et al. Phase II trial of paelitaxel by3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer [J]. J Clin Oncol,1995,13(10) : 2575 被引量：1
7Gori S, Moseoni AM ,Basurtol C, et al. Weekly paclitaxel in metastatic breast cancer patients: a phase 1I study[J]. Rumoil, 2002, 88:470 被引量：1
8Michaud LB, Valero V,Hortobagyi G. Risks and benefits of taxalLxes in breast and ocarian calmer[J]. Drug Safety, 2000, 23: 401 被引量：1
